Skip to main content

Table 3 Reproductive outcomes

From: GnRH antagonist rescue protocol combined with cabergoline versus cabergoline alone in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial

  Cabergoline group (n = 118) Antagonist rescue combined with cabergoline group (n = 118) Odd ratio (95 % CI) P value
Clinical pregnancy/started cycle 42/118(35.59 %) 46/118(38.98 %) 0.87[0.51–1.47] 0.59
Clinical pregnancy/transfer cycle 42/114(36.84 %) 46/118(38.98 %) 0.91[0.54–1.55] 0.74
Ongoing pregnancy/started cycle 37/118(31.36 %) 41/118(34.75 %) 0.86[0.5–1.48] 0.578
Ongoing pregnancy/transfer cycle 37/114(32.46 %) 41/118(34.75 %) 0.9[0.52–1.56] 0.708
Implantation rate 49/265(18.49 %) 53/267(19.85 %) 0.92[0.59–1.41] 0.689
Multiple pregnancy rate 7/42(16.67 %) 6/46(13.04 %) 1.33[0.41–4.34] 0.632
Spontaneous abortion rate 5/42(11.9 %) 5/46(10.87 %) 1.11[0.3–4.14] 0.879
  1. Values are expressed as n/n (%) unless otherwise indicated